In tumor immunotherapy, the activation of AMPK has been found to affect the phenotypic transformation and function of macrophages by focusing on solving metabolic problems such as FAO and mitochondrial metabolism, thereby enhancing the attack force of the immune system and reducing immune escape, ultimately enhancing the tumor-killing ability [105]. This evidence concerns the gene PRKAB1 and neoplasm.